⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2004BMJOpen Access

Making decisions about benefits and harms of medicines

Trisha Greenhalgh Olga Kostopoulou Clare Harries

View Full Paper

Ask AI

Bookmark

Share

Abstract

Even when good scientific data are available, people9s interpretation of risks and benefits will differ

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Greenhalgh et al. (2004) studied this question.

synapsesocial.com/papers/6aa25d08d081bdd435a72b29 https://doi.org/10.1136/bmj.329.7456.47

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alosetron and irritable bowel syndromeReview · 2003 · 72 citations
2Patient choice and complementary medicineOriginal Research · 2003 · 7 citations
3Pharmacogenetics—expectations and realityOriginal Research · 2004 · 45 citations
4The extent of patients' understanding of the risk of treatmentsOriginal Research · 2001 · 159 citations
5Presenting Risk Information A Review of the Effects of Framing and other Manipulations on Patient OutcomesRisk Assessment · 2001 · 491 citations

More related papers

Why do doctors use treatments that do not work?2004
An Alternative Metaphor in the Study of Judgment and Choice: People as Politicians1991
The power of stories over statistics2003

More from BMJ

Confidence intervals and statistical significanceWed,
Cameron launches challenge to end "national crisis" of poor dementia careTue,